Optinose Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Optinose Inc inventory turnover ratio, the Optinose Inc 's ability to sell and replace its inventory in the first quarter 2025, sequentially increased to 0.68 in the first quarter 2025, yet the ratio remained below the average, as OPTN's market remain challenging.Average inventory processing period, for the Optinose Inc in Mar 31 2025 quarter, has decreased to 537 days, compare to 562 days, in the Dec 31 2024 quarter.

Within Healthcare sector 350 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2025, to 1640, from total ranking in the fourth quarter 2024 at 1910.

OPTN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Optinose Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OPTN Inventory Turnover Ratio	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Inventory Growth	9.55 %	42.36 %	40.51 %	47.53 %	24.23 %
Y / Y Cost of Sales Growth	42.16 %	-8.31 %	-7.19 %	-22.95 %	-27.84 %
Inventory Turnover Ratio (TTM)	0.68	0.65	0.72	0.8	0.96
OPTN's Total Ranking	# 1640	# 1910	# 1588	# 1595	# 1293
Average inventory processing period	535	561	506	456	382
Seq. Inventory Growth	-1.42 %	1.43 %	-0.93 %	10.59 %	28.1 %
Seq. Cost of Sales Growth	-10.44 %	-5.38 %	4.24 %	60.93 %	-42.23 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 110
Healthcare Sector	# 351
Overall Market	# 1640

Inventory Turnover Ratio Statistics
High	Average	Low
1.19	0.77	0.2
(Dec 31 2019)		(Sep 30 2018)

OPTN Company Profile >> Back to OPTN Efficiency Comparisons >> Compare OPTN Inventory Turnover Ratio to its Competitors

Financial Statements
Optinose Inc 's Inventories	$ 11 Millions	Visit OPTN's Balance sheet
Optinose Inc 's Cost of Revenues TTM	$ 8 Millions	Visit OPTN's Income Statement
What are OPTN's Sales?		Visit OPTN's Sales by Segment

Other Inventory Turnover Ratios
Optinose Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
OPTN's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for OPTN's Competitors
Inventory Turnover Ratio for OPTN's Suppliers
Inventory Turnover Ratio for OPTN's Customers

You may also want to know
OPTN's Sales Growth Rates	OPTN's Pe Price to earnings ratio	OPTN's Receivables Turnover Ratio	OPTN's Stock Quote
OPTN's Net Income Growth Rates	OPTN's Ps Price to Sales ratio	OPTN's Sales per Employee	OPTN's Asset Turnover Ratio
OPTN's Net Margin	OPTN's Pb Price to Book ratio	OPTN's Financial Strength Ratios	OPTN's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2025	Inventories at quarter ending Mar 31 2025
Enzo Biochem Inc	1.88	$ 11.742 Millions	$ 6 Millions
Coherus Oncology inc	1.87	$ 85.620 Millions	$ 46 Millions
Neuroone Medical Technologies Corp	1.84	$ 3.494 Millions	$ 2 Millions
Eyepoint Inc	1.84	$ 5.033 Millions	$ 3 Millions
Sintx Technologies Inc	1.82	$ 0.834 Millions	$ 0 Millions
Bausch and Lomb Corp	1.81	$ 1,926.000 Millions	$ 1,064 Millions
Aytu Biopharma Inc	1.81	$ 21.000 Millions	$ 12 Millions
Utah Medical Products Inc	1.79	$ 15.982 Millions	$ 9 Millions
Beyond Air Inc	1.78	$ 4.200 Millions	$ 2 Millions
Nuwellis Inc	1.77	$ 3.235 Millions	$ 2 Millions
Sight Sciences Inc	1.76	$ 11.000 Millions	$ 6 Millions
Clearpoint Neuro Inc	1.75	$ 12.507 Millions	$ 7 Millions
Retractable Technologies Inc	1.75	$ 36.676 Millions	$ 21 Millions
Procept Biorobotics Corporation	1.74	$ 93.000 Millions	$ 53 Millions
Integra Lifesciences Holdings Corp	1.74	$ 754.649 Millions	$ 433 Millions
Amgen Inc	1.74	$ 12,626.000 Millions	$ 7,271 Millions
Yunhong Green Cti Ltd	1.73	$ 14.000 Millions	$ 8 Millions
Artivion Inc	1.71	$ 140.000 Millions	$ 82 Millions
Lifeloc Technologies Inc	1.70	$ 5.134 Millions	$ 3 Millions
Haemonetics Corporation	1.70	$ 611.000 Millions	$ 360 Millions
Staar Surgical Co	1.70	$ 72.582 Millions	$ 43 Millions
Conmed Corporation	1.69	$ 577.179 Millions	$ 342 Millions
Glaukos Corp	1.68	$ 98.000 Millions	$ 58 Millions
Biotricity Inc	1.67	$ 3.000 Millions	$ 2 Millions
Arcutis Biotherapeutics Inc	1.67	$ 24.702 Millions	$ 15 Millions
Inspire Medical Systems inc	1.67	$ 128.000 Millions	$ 77 Millions
Quanterix Corporation	1.67	$ 54.186 Millions	$ 32 Millions
Neuropace Inc	1.67	$ 21.000 Millions	$ 13 Millions
Stryker Corp	1.66	$ 8,367.000 Millions	$ 5,054 Millions
Tela Bio Inc	1.65	$ 22.000 Millions	$ 13 Millions

Date modified: 2026-08-29T17:41:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.